Asia Pacific Hypodermic Needles Market

The Asia Pacific hypodermic needles market is expected to reach US$ 1,092.6 million by 2028 from US$ 668.7 million in 2021. The market is estimated to grow at a CAGR of 7.3% from 2021–2028.

The demand for hypodermic needles is growing continuously as the demand for the vaccine is increasing for COVID-19. Thus, the market players are actively involved in the market development activities in the COVID-19 pandemic. For instance, In April 2021, Misawa Medical Industry Co., Ltd. has developed "Low Dead Space Needles," which can reduce the quantity of medicinal liquid left in the syringe and will begin selling them in Japan on April 1, 2021. This eliminates the need for a particular syringe and reduces the "dead space" in which the liquid lingers in the syringe. Furthermore, one vial of the new COVID vaccines developed by Pfizer Inc can offer six injections. In June 2020, Misawa Medical Industry Co., Ltd. extended its needle manufacturing facilities, boosting its annual production capacity from 1.9 billion to 3 billion pieces. The company is currently strengthening the vaccine needle production system while employing other product production lines, and the company will continue to make efforts to make vaccination easier.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the hypodermic needles market. The Asia Pacific hypodermic needles market is expected to grow at a good CAGR during the forecast period.

Asia Pacific Hypodermic Needles Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Hypodermic Needles Market Segmentation 

By Type

• Safety Needles
  • Retractable Needles
  • Non-retractable Needles
• Non-safety Needles

By Application

• Drug Delivery
• Vaccination
• Blood Specimen Collection

By End User

• Hospitals and Clinics
• Diagnostic Centers
• Home Health Care

By Usage

• Disposable
• Reusable

By Country

• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific

Companies Mentioned

• Terumo Corporation
• BD
• B. Braun Melsungen AG
• Catalent Inc
• Cardinal Health Inc
• Vygon
• Barber of Sheffield
• Nipro Corp.

Asia Pacific Hypodermic Needles Strategic Insights

Strategic insights for the Asia Pacific Hypodermic Needles provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Asia Pacific Hypodermic Needles Report Scope

Asia Pacific Hypodermic Needles Regional Insights

The geographic scope of the Asia Pacific Hypodermic Needles refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.